Literature DB >> 31270855

Diagnosis and management of follicular lymphoma: A comprehensive review.

Reyad Dada1,2.   

Abstract

Follicular Lymphoma (FL) is an indolent lymphoma and may have various clinical courses. Worldwide, FL is the second most common non-Hodgkin lymphoma (NHL) type after diffuse large B-cell lymphoma. In this review article, the author is discussing relevant diagnostic tools, prognostic factors, and updated study results on the management of patients with newly diagnosed and relapsed/refractory FL. Controversies in the treatment, maintenance therapy, stem cell transplantation, and novel treatment approaches will be comprehensively discussed.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  follicular lymphoma; indolent lymphoma; low-grade lymphoma

Year:  2019        PMID： 31270855     DOI： 10.1111/ejh.13271

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


  10 in total

1.  Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies.

Authors:  Natsumi Kawasaki; Yoriko Yamashita-Kashima; Takaaki Fujimura; Shigeki Yoshiura; Naoki Harada; Osamu Kondoh; Yasushi Yoshimura
Journal:  Mol Biol Rep       Date:  2022-02-26       Impact factor: 2.742

Review 2.  Crohn's Disease Following Rituximab Treatment for Follicular Lymphoma in a Patient with Synchronous Gastric Signet Ring Cells Carcinoma: A Case Report and Literature Review.

Authors:  Elisabetta Cavalcanti; Raffaele Armentano; Ivan Lolli
Journal:  Cancer Res Treat       Date:  2020-07-13       Impact factor: 4.679

Review 3.  Copanlisib for the Treatment of Malignant Lymphoma: Clinical Experience and Future Perspectives.

Authors:  Javier Munoz; George A Follows; Loretta J Nastoupil
Journal:  Target Oncol       Date:  2021-03-09       Impact factor: 4.493

4.  Evans syndrome in adults: an observational multicenter study.

Authors:  Bruno Fattizzo; Marc Michel; Juri Alessandro Giannotta; Dennis Lund Hansen; Maria Arguello; Emanuele Sutto; Nicola Bianchetti; Andrea Patriarca; Silvia Cantoni; María Eva Mingot-Castellano; Vickie McDonald; Marco Capecchi; Anna Zaninoni; Dario Consonni; Josephine Mathilde Vos; Nicola Vianelli; Frederick Chen; Andreas Glenthøj; Henrik Frederiksen; Tomás José González-López; Wilma Barcellini
Journal:  Blood Adv       Date:  2021-12-28

5.  Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome.

Authors:  Shuyan Yao; Zhili Jin; Lingbo He; Ruoxi Zhang; Menghan Liu; Zhengjie Hua; Zhao Wang; Yini Wang
Journal:  Front Oncol       Date:  2021-12-06       Impact factor: 6.244

6.  Approaches to Selecting "Time Zero" in External Control Arms with Multiple Potential Entry Points: A Simulation Study of 8 Approaches.

Authors:  Anthony J Hatswell; Kevin Deighton; Julia Thornton Snider; M Alan Brookhart; Imi Faghmous; Anik R Patel
Journal:  Med Decis Making       Date:  2022-05-06       Impact factor: 2.749

7.  Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.

Authors:  Musa Alzahrani; Mubarak M Al-Mansour; John Apostolidis; Ahmed Barefah; Reyad Dada; Ayman Alhejazi; Yasir Alayed; Ibraheem Motabi; Mansoor Radwi; Hani Al-Hashmi
Journal:  Saudi J Med Med Sci       Date:  2020-08-20

8.  3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma.

Authors:  Fabien Gava; Carla Faria; Pauline Gravelle; Juan G Valero; Cèlia Dobaño-López; Renaud Morin; Marine Norlund; Aurélie Gomes; Jean-Michel Lagarde; Cédric Rossi; Julie Bordenave; Laetitia Pieruccioni; Jacques Rouquette; Alba Matas-Céspedes; Jean-Jacques Fournié; Loïc Ysebaert; Camille Laurent; Patricia Pérez-Galán; Christine Bezombes
Journal:  Cancers (Basel)       Date:  2021-03-24       Impact factor: 6.639

9.  Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma.

Authors:  Cédric Rossi; Marie Tosolini; Pauline Gravelle; Sarah Pericart; Salim Kanoun; Solene Evrard; Julia Gilhodes; Don-Marc Franchini; Nadia Amara; Charlotte Syrykh; Pierre Bories; Lucie Oberic; Loïc Ysebaert; Laurent Martin; Selim Ramla; Philippine Robert; Claire Tabouret-Viaud; René-Olivier Casasnovas; Jean-Jacques Fournié; Christine Bezombes; Camille Laurent
Journal:  Haematologica       Date:  2022-01-01       Impact factor: 9.941

Review 10.  Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies.

Authors:  Thomas D Rodgers; Carla Casulo; Frederic Boissard; Aino Launonen; Joana Parreira; Guillaume Cartron
Journal:  Oncol Ther       Date:  2021-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.